Bank of Montreal’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bank of Montreal’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-110	Closed	-$9K	–	5041
2018 Q3	$9K	Hold	110	–	–	﹤0.01%	3975
2018 Q2	$11K	Buy	+110	New	+$9.5K	﹤0.01%	3946
2016 Q4	–	Sell	-9,626	Closed	-$1.2M	–	4303
2016 Q3	$1.2M	Buy	+9,626	New	+$1.14M	﹤0.01%	1743
2015 Q3	–	Sell	-2,000	Closed	-$230K	–	4284
2015 Q2	$230K	Buy	+2,000	New	+$210K	﹤0.01%	2346

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's CBPO Position: Q4 2018 in Review

Bank of Montreal sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 110 shares — an estimated $9K sold.

Bank of Montreal first reported a position in CBPO in Q2 2015 and held it in 4 quarters. The position peaked at $1.2M in Q3 2016. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

Bank of Montreal reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
Bank of Montreal sold 110 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $9K.
Bank of Montreal first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 4 quarters.
Bank of Montreal's China Biologic Products Holdings, Inc. position peaked at $1.2M in Q3 2016.
67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Bank of Montreal's 13F filing for Q4 2018, filed 22 Jan 2019.